TARDBP gene – Talk Bio

Actionable Insights Powered by AI

Voyager Therapeutics Partners with Transition Bio for Small Molecule Neurodegenerative Drug Discovery; CRISPR Therapeutics Ends Work on CAR-T Therapy

1 month ago talkbio0Tagged Amyotrophic Lateral Sclerosis, CAR-T therapy, Clustered Regularly Interspaced Short Palindromic Repeats, Drug Development, Neurodegenerative Disorders, Partnership, Pick Disease of the Brain, small molecule drug discovery, TARDBP gene, Transition Bio, Voyager Therapeutics

Voyager Therapeutics; Transition Bio; ALS; frontotemporal dementia; TDP-43; small molecule drug discovery; neurodegenerative diseases; CRISPR Therapeutics; CAR-T therapy; partnership; drug development

Mitsubishi Tanabe and Dewpoint Therapeutics Collaborate on $480M ALS Treatment Development

1 year ago talkbio0Tagged Amyotrophic Lateral Sclerosis, biobucks, Dewpoint Therapeutics, Mitsubishi, small molecule condensate modulator, Tanabe Pharma, TARDBP gene

ALS treatment, Dewpoint Therapeutics, Mitsubishi Tanabe Pharma Corporation, TDP-43, small molecule condensate modulator, biobucks deal